Search from the table of contents of 2.5 million books
Advanced Search (Beta)
Home > Antiprotozoal Drug Development and Delivery > Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs
Antiprotozoal Drug Development and Delivery |
Alane Beatriz Vermelho; Claudiu T. Supuran
Springer International Publishing
Antiprotozoal Drug Development and Delivery
Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs
Authors

Douglas O. Escrivani; Gabriela C. Mattos; Bartira Rossi-Bergmann; Ariane J. Sousa-Batista

ARI Id

1665394650039_6238223

Access

Not Available Free

Pages

181-217

DOI

10.1007/7355_2021_134

Chapter URL

https://rd.springer.com/chapter/10.1007/7355_2021_134

Table of Contents of Book
Showing 1 to 16 of 16 entries
Chapters/HeadingsAuthor(s)PagesInfo
Front Matter
i-x
Classical and Modern Drug Treatments for Leishmaniasis
Dirlei Nico; Luciana Conde; Clarisa Beatriz Palatnik de Sousa
1-21
Saponins as Potential Antiprotozoal Agents
Ana Claudia F. Amaral; Aline de S. Ramos; José Luiz P. Ferreira; Maíra Martins H. de Almeida; Jefferson D. da Cruz; Danielle L. de Oliveira et al.
23-48
Chagas Disease: Drug Development and Parasite Targets
Alane Beatriz Vermelho; Verônica Cardoso; Felipe Raposo Passos Mansoldo; Claudiu T. Supuran; Sabrina Martins Lage Cedrola; Igor Almeida Rodrigues et al.
49-81
Targeting Carbonic Anhydrases from Trypanosoma cruzi and Leishmania spp. as a Therapeutic Strategy to Obtain New Antiprotozoal Drugs
Alessio Nocentini; Alane B. Vermelho; Claudiu T. Supuran
83-111
New Compounds for the Management of Trypanosoma brucei Infection
Grazia Luisi; Simone Carradori
113-141
Polyamine and Trypanothione Pathways as Targets for Novel Antileishmanial Drugs
Igor A. Rodrigues; Andreza R. Garcia; Mariana M. Paz; Rogério G. D. Grilo Junior; Ana Claudia F. Amaral; Anderson S. Pinheiro
143-180
Nano and Microstructured Delivery Systems for Current Antileishmanial Drugs
Douglas O. Escrivani; Gabriela C. Mattos; Bartira Rossi-Bergmann; Ariane J. Sousa-Batista
181-217
Pharmacological Treatment of Malaria
Elizabeth A. Lopes; Maria M. M. Santos; Mattia Mori
219-240
η-Class Carbonic Anhydrases as Antiplasmodial Drug Targets: Current State of the Art and Hurdles to Develop New Antimalarials
Clemente Capasso; Claudiu T. Supuran
241-258
Management of Entamoeba histolytica Infection: Treatment Strategies and Possible New Drug Targets
Susanna Haapanen; Seppo Parkkila
259-269
Trichomonas vaginalis Pharmacological Treatment
Seppo Parkkila
271-278
Beta-Carbonic Anhydrase 1 from Trichomonas Vaginalis as New Antiprotozoan Drug Target
Claudiu T. Supuran; Anna Di Fiore; Seppo Parkkila; Giuseppina De Simone
279-292
Treatment of Toxoplasmosis: An Insight on Epigenetic Drugs
Paolo Guglielmi; Daniela Secci
293-319
Challenges and Promises for Obtaining New Antiprotozoal Drugs: What’s Going Wrong?
Alane Beatriz Vermelho; Mattia Mori; William A. Donald; Claudiu T. Supuran
321-329
Correction to: Chagas Disease: Drug Development and Parasite Targets
Alane Beatriz Vermelho; Verônica Cardoso; Felipe Raposo Passos Mansoldo; Claudiu T. Supuran; Sabrina Martins Lage Cedrola; Igor Almeida Rodrigues et al.
331-331
Chapters/HeadingsAuthor(s)PagesInfo
Showing 1 to 16 of 16 entries
Similar Books
Similar Chapters
Similar Thesis

Similar News

Similar Articles
Similar Article Headings